Atlas Trials

Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets

Clinical trial NCT05355077 · WITHDRAWN

Trial details

NCT number
NCT05355077
Sponsor
Shanghai Vinnerna Biosciences Co., Ltd.
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2022-05-02
Primary completion
2022-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.